+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a continuous glucose monitoring system for use in veterinary medicine

Evaluation of a continuous glucose monitoring system for use in veterinary medicine

Diabetes Technology and Therapeutics 7(6): 885-895

With the emergence of continuous glucose monitoring systems being used to provide a detailed glucose picture in humans, a commercially available system (CGMS(R), Medtronic Minimed, Northridge, CA) was examined for use in veterinary species. Adult, clinically normal horses (n = 7), cats (n = 3), dogs (n = 4), and cows (n = 5) were studied. Cats (n = 4), dogs (n = 5), and one horse with diabetes were included in the study. Several of the normal horses, including the horse with diabetes, and one cow were subjected to an intravenous glucose tolerance test. The CGMS was attached to each animal, and the recorded interstitial glucose concentrations were compared with whole blood glucose concentrations as determined by a point-of-care glucose meter. Events such as insulin administration, feeding, travel, or administration of intravenous glucose were all noted and compared with results from the CGMS. There was a positive correlation between interstitial and whole blood glucose concentrations for all the clinically normal species, those with diabetes mellitus, and those receiving intravenous glucose. Events such as feeding, glucose or insulin administration, and transport to the clinic were noted by the owner or clinician and could be identified on the graph and correlated with time of occurrence. Our data indicate that the use of the CGMS is valid for use in the species examined. Use of this system alleviated the need for multiple blood samples and the stress associated with obtaining those samples. This system may provide greater monitoring capabilities in patients with diabetes and promote the diagnostic and research potential of serial glucose monitoring in veterinary species.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 048993359

Download citation: RISBibTeXText

PMID: 16386094

DOI: 10.1089/dia.2005.7.885

Related references

Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring. Diabetes and Metabolism Journal 40(4): 326-333, 2016

Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technology and Therapeutics 8(6): 627-635, 2006

Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Technology and Therapeutics 11(3): 145-150, 2009

Non-invasive, continuous glucose monitoring system Evaluation by means of glucose clamps. Diabetes 52(Suppl. 1): A433-A434, 2003

Evaluation of glucose response to 3 types of insulin using a continuous glucose monitoring system in healthy alpacas. Journal of Veterinary Internal Medicine 28(5): 1613-1620, 2015

Evaluation of a non-invasive, continuous glucose monitoring system in patients with diabetes Results of a glucose clamp Study. Diabetes 52(Suppl. 1): A91, 2003

Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 90(6): 3387-3391, 2005

Use of the continuous glucose monitoring system to treat insulin autoimmune syndrome: quantification of glucose excursions and evaluation of treatment efficacy. Diabetic Medicine 31(7): E20-E24, 2014

Evaluation of a non-invasive, continuous glucose monitoring system in patients with diabetes Results of a glucose clamp study with hypoglycemic and hyperglycemic excursions. Diabetologia 46(Suppl. 2): A45, 2003

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Health Technology Assessment 20(17): V-Xxxi 1-251, 2016

Evaluation of the performance of a novel system for continuous glucose monitoring. Journal of Diabetes Science and Technology 7(4): 815-823, 2013

Continuous glucose monitoring system versus self-monitoring blood glucose in order to improve night-time glucose profile in subjects with Type 1 diabetes The NOCTURNO study. Diabetes & Metabolism 29(Hors serie 2): 4S196, 2003

Evaluation of an open access software for calculating glucose variability parameters of a continuous glucose monitoring system applied at pediatric intensive care unit. Biomedical Engineering Online 14: 37, 2015

Evaluation of a continuous glucose monitoring system in diabetic dogs. Journal of Small Animal Practice 44(10): 435-442, 2003

Development of a continuous glucose monitoring system An in vitro evaluation. Pharmaceutical Research (New York) 9(10 Suppl. ): S353, 1992